PharmExec Direct:
Having trouble viewing this e-mail? Click here.
PharmExec Direct | From the editors of Pharmaceutical Executive Visit the PharmExec website
Send Us Some Feedback
 
| Update My Profile | Advertise With Us | Visit PharmExec.com |
PRINT SUBSCRIBE | DIGITAL SUBSCRIBE
September 12, 2013 | ISSUE NUMBER 317 VOL 11

Healthcare Reform
Rx Brand Managers: Will Your Product Be Covered Under Obamacare?
We are now less than three weeks away from the initial sign up period for Obamacare. After October 1st, the reality of the program and all that it portends for the future of the US pharmaceutical industry will begin to make itself apparent. One area that is of extreme concern to Rx brand managers across the country is, “Will my drug be covered?” The apparent answer to that important question is — it depends. Tom Norton reports ...Read more

Smart Sourcing Strategy: A Whitepaper on Pharmacovigilance Vendor Selection
Strategic planning, sourcing and implementation of pharmacovigilance operations are multi-dimensional activities. There has been a considerable increase in the quality and quantity of safety processes being outsourced due to evolution of mature processes; risk mitigation strategies and increase in vendor experiences that has helped the sponsor balance core in-house strength and leverage the service provider’s capabilities. Learn how to adopt a Smart Sourcing Strategy www.sciformix.com/smartsourcingstrategy

Regulatory
With Cannabis, Science Trumps Culture, Says GW Pharma CEO
Already approved in over 20 countries, GW Pharma’s Sativex product, if approved by FDA, would become the first prescription drug derived from raw cannabis. Sativex has entered phase III trials in US, but Justin Gover, GW Pharma's CEO, says the product’s forward march in the US regulatory system is in spite of, not because of a shifting cultural perception of marijuana and its therapeutic potential
...Read more

M&A
Omnicom & Publicis: 5 Questions to Frame the Deal
Just what are the benefits of the large public agency/marketing conglomerates? Al Topin steps forward to air his confusion over the reasons behind the Omnicom/Publicis merger
...Read more

Technology
Why the Smartwatch Should Make Time for Health
The smartwatch is stepping tentatively into the dynamic mobile communications arena. But it has a long way to go before it becomes a disruptive technology. Key to its adoption may be its approach to digital health, writes Peter Houston
...Read more

Social Media
Crisis Preparedness in an ‘Always On’ Digital World
The first 120 minutes of a crisis can determine the public’s perception of an organization. And in today’s digital world, companies are more at risk than ever to viral attacks from unexpected sources. For the pharma industry, in particular, being prepared to respond and shape the conversation around your brand and company is critical, write Laura Schoen andStacey Bernstein
...Read more

New eBook
The Best of the Successful Product Manager's Handbook Volume IV
In the fourth volume of this four-volume set from the pages of Pharmaceutical Executive, you'll arm yourself with information and expert accounts to fortify your marketing plans against both the unexpected and the inevitable
...Read more

//The American Chemical Society CAS Division (Columbus, OH) has appointed Manuel (Manny) Guzman as its next President. Guzman will begin his appointment on Sept. 30. He succeeds Robert J. Massie, who has led CAS for more than 21 years.//SNBL USA (Everett, WA) announced the appointment of Paris-based Janet Kelly as its new Director of Business Development for Europe.//Theorem Clinical Research (King of Prussia, PA) promoted veteran UK researcher Phil Lake to head its biopharmaceutical franchise in respiratory.//Catalent Pharma Solutions (Somerset, NJ) named David Heyens in the new role of President, Catalent Asia Pacific.//AMAG Pharmaceuticals, Inc. (Lexington, MA) announced that Barbara Deptula, former Executive VP and Chief Corporate Development Officer of Shire, has been elected to its Board of Directors.//NSF International (Ann Arbor, MI) appointed George Toscano as Senior Director of Quality Systems, Pharmaceuticals, Biotech and Biologics.//

September 18: Life Sciences Financial Transformation Summit
Philadelphia, PA.


October 2–4: How To Increase Patient Compliance, Improve Health Outcomes, & Lower Costs Through The Latest Digital Strategies
New York, NY.


October 14­–16: Healthcare Informatics session, Inaugural Strategic Business Exchange
San Antonio, TX.


November 13–15: 2013 HBA Leadership Conference
Boston, MA.


 
Follow Pharm Exec on Twitter
Follow Pharm Exec on Facebook
Follow Pharm Exec on Linkedin

 

Survey
Are stricter regulatory procedures restricting pharma industry growth?

Click To Vote
 

Quick Links

Read the Pharm Exec Global Digest — Market Access Special

Biopharma Innovation in Trouble?

Evaluating Big Pharma’s Manufacturing Investment Plans